Browse the complete record of transactions filed by HENNEMAN JOHN B III, Director. Director active across 7 companies, notably Anika Therapeutics, Inc.. In total, 13 disclosures have been published. Total volume traded: €140k. The latest transaction was filed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
John B. Henneman III is a Director at Anika Therapeutics, Inc., SeaSpine Holdings Corp, and Aprea Therapeutics, Inc. He plays a vital role in overseeing the activities and strategies of these companies. His expertise in biotechnology and medical devices allows him to make significant contributions to the boards. John is committed to promoting innovation and growth in these sectors.